We are live on ! Find out more
BC

Burleson & Co Portfolio holdings

AUM $401M
1-Year Est. Return 25.44%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
-25.44%
3 Year Est. Return
+49.06%
5 Year Est. Return
+69.5%
10 Year Est. Return
AUM
$401M
AUM Growth
-$64.4M
Cap. Flow
-$74.6M
Cap. Flow %
-18.62%
Top 10 Hldgs %
34.81%
Holding
465
New
32
Increased
98
Reduced
73
Closed
38

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.59M
2
ACN icon
Accenture
ACN
+$1.54M
3
TMO icon
Thermo Fisher Scientific
TMO
+$1.53M
4
LIN icon
Linde
LIN
+$1.42M
5
NEE icon
NextEra Energy
NEE
+$1.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$19.4M
2
NVDA icon
NVIDIA
NVDA
+$9.7M
3
NFLX icon
Netflix
NFLX
+$9M
4
STEM icon
Stem
STEM
+$6.57M
5
AMZN icon
Amazon
AMZN
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Consumer Discretionary 10.71%
3 Healthcare 8.97%
4 Financials 8.97%
5 Communication Services 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWZ icon
326
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$270M
$2.19K ﹤0.01%
81
IVOL icon
327
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$272M
$2.18K ﹤0.01%
96
ZUO
328
DELISTED
Zuora, Inc.
ZUO
$2.16K ﹤0.01%
340
SPCE icon
329
Virgin Galactic
SPCE
$371M
$2.09K ﹤0.01%
30
ANET icon
330
Arista Networks
ANET
$248B
$2.06K ﹤0.01%
68
BSX icon
331
Boston Scientific
BSX
$69.2B
$2.04K ﹤0.01%
44
VWOB icon
332
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.18B
$2.01K ﹤0.01%
33
QNCX icon
333
CALL
Quince Therapeutics
QNCX
$28.2M
$1.82K ﹤0.01%
421
-398
-49% -$66.6K
SNAP icon
334
Snap
SNAP
$8.97B
$1.79K ﹤0.01%
200
SYK icon
335
Stryker
SYK
$129B
$1.76K ﹤0.01%
7
VMC icon
336
Vulcan Materials
VMC
$37.2B
$1.76K ﹤0.01%
10
P
337
Everpure Inc
P
$27.8B
$1.61K ﹤0.01%
60
SLG icon
338
SL Green Realty
SLG
$3.9B
$1.44K ﹤0.01%
43
+1
+2% +$38
CHPT icon
339
ChargePoint
CHPT
$150M
$1.35K ﹤0.01%
7
IXUS icon
340
iShares Core MSCI Total International Stock ETF
IXUS
$59.7B
$1.31K ﹤0.01%
23
+1
+5% +$56
DSI icon
341
iShares MSCI KLD 400 Social ETF
DSI
$5.52B
$1.22K ﹤0.01%
+17
New +$1.22K
VXF icon
342
Vanguard Extended Market ETF
VXF
$31.3B
$1.2K ﹤0.01%
9
HAL icon
343
Halliburton
HAL
$26.6B
$1.17K ﹤0.01%
30
KNDI
344
Kandi Technologies Group
KNDI
$69.8M
$1.15K ﹤0.01%
500
GNRC icon
345
Generac Holdings
GNRC
$12.8B
$1.11K ﹤0.01%
11
EAGG icon
346
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.98B
$1.07K ﹤0.01%
+23
New +$1.07K
BILL icon
347
BILL Holdings
BILL
$4.81B
$981 ﹤0.01%
9
+4
+80% +$480
MUB icon
348
iShares National Muni Bond ETF
MUB
$45.4B
$965 ﹤0.01%
9
ACER
349
DELISTED
Acer Therapeutics Inc
ACER
$916 ﹤0.01%
365
GT icon
350
Goodyear
GT
$1.99B
$914 ﹤0.01%
90

Similar funds

Burleson & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Burleson & Co held 465 positions worth $401M, down 14% from $465M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Burleson & Co withdrew a net $74.6M in Q4 2022, closing 38 positions and reducing 73 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $19.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Burleson & Co opened a new position in State Street SPDR Portfolio Long Term Treasury ETF worth $514K.

  • Burleson & Co's largest Q4 2022 buy was State Street SPDR Portfolio Long Term Treasury ETF: 17,716 shares worth $514K.
  • Burleson & Co added most to Danaher in Q4 2022, an estimated $1.59M increase.
  • Burleson & Co's biggest Q4 2022 reduction was NVIDIA, cutting an estimated $9.7M.
  • Burleson & Co fully exited Invesco QQQ Trust in Q4 2022, selling an estimated $19.4M.
  • Burleson & Co's ten largest holdings make up 35% of its $401M portfolio in Q4 2022.
  • Burleson & Co opened 32 new positions and closed 38 in Q4 2022.
  • Burleson & Co's portfolio value fell 14% quarter-over-quarter to $401M.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.